Cargando…
Guillain–Barré syndrome and anti-ganglioside antibodies: a clinician-scientist’s journey
Guillain–Barré syndrome (GBS) is the most frequent cause of acute flaccid paralysis. Having seen my first GBS patient in 1989, I have since then dedicated my time in research towards understanding the pathogenesis of GBS. Along with several colleagues, we identified IgG autoantibodies against gangli...
Autor principal: | YUKI, Nobuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Academy
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422685/ https://www.ncbi.nlm.nih.gov/pubmed/22850724 http://dx.doi.org/10.2183/pjab.88.299 |
Ejemplares similares
-
Detection of anti-ganglioside antibodies in Guillain-Barré syndrome
por: Zhu, Wenli, et al.
Publicado: (2021) -
Association of anti‐gangliosides antibodies and anti‐CMV antibodies in Guillain–Barré syndrome
por: Wang, Lijuan, et al.
Publicado: (2017) -
Role of Anti-ganglioside Antibodies in the Diagnosis of Guillain-Barré Syndrome as an Alternate Investigation
por: Saeed, Muhammad Luqman, et al.
Publicado: (2019) -
Anti-ganglioside Antibodies in Guillain-Barre Syndrome: A Novel Immunoblotting-Panel Assay
por: Zhu, Jiting, et al.
Publicado: (2021) -
The Association of Anti-Ganglioside Antibodies in the Pathogenesis and Development of Zika-Associated Guillain-Barré Syndrome
por: Mohite, Divya, et al.
Publicado: (2020)